SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001213900-22-007163
Filing Date
2022-02-14
Accepted
2022-02-14 06:05:29
Documents
13

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT defm14a4_helixacq.htm DEFM14A 15812918
2 GRAPHIC tchart_001.jpg GRAPHIC 335401
3 GRAPHIC tchart_002.jpg GRAPHIC 396517
4 GRAPHIC tchart_003.jpg GRAPHIC 324806
5 GRAPHIC timage_005.jpg GRAPHIC 196165
6 GRAPHIC timage_004.jpg GRAPHIC 193389
7 GRAPHIC timage_006.jpg GRAPHIC 546734
8 GRAPHIC timage_007.jpg GRAPHIC 236620
9 GRAPHIC tchart_008.jpg GRAPHIC 464904
10 GRAPHIC tsvbleer_logo.jpg GRAPHIC 55371
11 GRAPHIC tsvbleer_footer.jpg GRAPHIC 112991
12 GRAPHIC tproxy_001.jpg GRAPHIC 1452215
13 GRAPHIC tproxy_002.jpg GRAPHIC 2397114
  Complete submission text file 0001213900-22-007163.txt   25061157
Mailing Address C/O CORMORANT ASSET MANAGEMENT, LLP 200 CLARENDON STREET FL 52 BOSTON MA 02116
Business Address C/O CORMORANT ASSET MANAGEMENT, LLP 200 CLARENDON STREET FL 52 BOSTON MA 02116 857 702 0370
Helix Acquisition Corp (Filer) CIK: 0001821586 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-39630 | Film No.: 22624456
SIC: 2834 Pharmaceutical Preparations